11th Mar 2009 07:00
For filings with the FSA include the annex For filings with issuer exclude the annex |
TR-1: Notifications of Major Interests in Shares |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Celsis International Plc |
2. Reason for notification (yes/no) |
|
An acquisition or disposal of voting rights |
Yes |
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
An event changing the breakdown of voting rights |
|
Other (please specify):______________ |
3. Full name of person(s) subject to notification obligation: |
|
North Atlantic Value LLP (as investment manager/advisor) |
4. Full name of shareholder(s) (if different from 3): |
1.
2. |
Oryx International Growth Fund Limited North Atlantic Smaller Companies Investment Trust Plc |
5. Date of transaction (and date on which the threshold is crossed or reached if different): |
9 March 2009
|
|
6. Date on which issuer notified: |
10 March 2009
|
|
7. Threshold(s) that is/are crossed or reached: |
Total holding increased through 17% and individual holding increased through 11%
|
8: Notified Details |
|||||||
A: Voting rights attached to shares |
|||||||
Class/type of shares If possible use ISIN code |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
|||||
Number of shares |
Number of voting rights |
Number of shares |
Number of voting rights |
Percentage of voting rights |
|||
Direct |
Indirect |
Direct |
Indirect |
||||
Ordinary shares Sedol. B0CD5F6 |
|||||||
Holder 1 | 1,500,000 | 1,500,000 | 1,500,000 | 1,500,000 | 6.85% | ||
Holder 2 | 2,191,440 | 2,191,440 | 2,426,440 | 2,426,440 | 11.08% | ||
Total: | 17.93% |
B: Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
Total (A+B) |
|
Number of voting rights |
Percentage of voting rights |
3,926,440 |
17.93% |
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
Not Applicable |
Proxy Voting: |
|
10. Name of proxy holder: |
N/A |
11. Number of voting rights proxy holder will cease to hold: |
N/A |
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
13. Additional information: |
North Atlantic Value LLP is the investment manager/advisor in respect of the full 17.93% holding as it is investment manager to Holder 1 as well as Holder 2. |
14 Contact name: |
Bonita Guntrip |
15. Contact telephone number: |
0207 747 5681 |
For notes on how to complete form TR-1 please see the FSA website.
Related Shares:
Celadon PharmaceuticalsNorth Atl.smlrOryx International Growth